Measurable residual disease in chronic myeloid leukemia

por Branford, Susan, Apperley, Jane F.
Publicado 2022

Molecular techniques for the personalised management of patients with chronic myeloid leukaemia

por Alikian, Mary, Gale, Robert Peter, Apperley, Jane F, Foroni, Letizia
Publicado 2017

The UK SPIRIT 1 trial in newly-diagnosed chronic myeloid leukaemia (CML)

por Gallipoli, Paolo, Clark, Richard E, Byrne, Jenny, Apperley, Jane F, Milojkovic, Dragana, Foroni, Letizia, Goldman, John M, O’Brien, Stephen
Publicado 2022

Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review

por Cortes, Jorge E., Apperley, Jane F., DeAngelo, Daniel J., Deininger, Michael W., Kota, Vamsi K., Rousselot, Philippe, Gambacorti-Passerini, Carlo
Publicado 2018

FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions

por May, Philippa C., Reid, Alistair G., Robinson, Mark E., Khorashad, Jamshid S., Milojkovic, Dragana, Claudiani, Simone, Willis, Fenella, Apperley, Jane F., Innes, Andrew J.
Publicado 2023

MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia

por Claudiani, Simone, Gatenby, Aoife, Szydlo, Richard, Nesr, George, Abulafia, Adi Shacham, Palanicawandar, Renuka, Nteliopoulos, Georgios, Khorashad, Jamshid, Foroni, Letizia, Apperley, Jane F., Milojkovic, Dragana
Publicado 2019

Lineage-Specific Genes Are Prominent DNA Damage Hotspots during Leukemic Transformation of B Cell Precursors

por Boulianne, Bryant, Robinson, Mark E., May, Philippa C., Castellano, Leandro, Blighe, Kevin, Thomas, Jennifer, Reid, Alistair, Müschen, Markus, Apperley, Jane F., Stebbing, Justin, Feldhahn, Niklas
Publicado 2017

Protease nexin-1 prevents growth of human B cell lymphoma via inhibition of sonic hedgehog signaling

por Xin, Xiangke, Ding, Yunchuan, Yang, Ying, Fu, Xing, Zhou, Jianfeng, McKee, Chad M., Muschel, Ruth J., Gale, Robert P., Apperley, Jane F., Xu, Danmei
Publicado 2018

FISH mapping of Philadelphia negative BCR/ABL1 positive CML

por Virgili, Anna, Brazma, Diana, Reid, Alistair G, Howard-Reeves, Julie, Valgañón, Mikel, Chanalaris, Anastasios, De Melo, Valeria AS, Marin, David, Apperley, Jane F, Grace, Colin, Nacheva, Ellie P
Publicado 2008

Validation of CIP2A as a Biomarker of Subsequent Disease Progression and Treatment Failure in Chronic Myeloid Leukaemia

por Clark, Richard E., Basabrain, Ammar A., Austin, Gemma M., Holcroft, Alison K., Loaiza, Sandra, Apperley, Jane F., Law, Christopher, Scott, Laura, Parry, Alexandra D., Bonnett, Laura, Lucas, Claire M.
Publicado 2021

Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib

por Ottmann, Oliver, Saglio, Giuseppe, Apperley, Jane F., Arthur, Christopher, Bullorsky, Eduardo, Charbonnier, Aude, Dipersio, John F., Kantarjian, Hagop, Khoury, Hanna Jean, Kim, Dong-Wook, Healey, Diane, Strauss, Lewis, Cortes, Jorge E.
Publicado 2018

A retrospective observational research study to describe the real‐world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands

por Claudiani, Simone, Janssen, Jeroen J. W. M., Byrne, Jenny, Smith, Graeme, Blijlevens, Nicole, Raghavan, Manoj, Smith, Matthew, Clark, Richard E., Mclain‐Smith, Susan, Carter, Angela M., Milojkovic, Dragana, Apperley, Jane F.
Publicado 2022

Combined Inhibition of p97 and the Proteasome Causes Lethal Disruption of the Secretory Apparatus in Multiple Myeloma Cells

por Auner, Holger W., Moody, Anne Marie, Ward, Theresa H., Kraus, Marianne, Milan, Enrico, May, Philippa, Chaidos, Aristeidis, Driessen, Christoph, Cenci, Simone, Dazzi, Francesco, Rahemtulla, Amin, Apperley, Jane F., Karadimitris, Anastasios, Dillon, Niall
Publicado 2013

European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia

por Cross, Nicholas C. P., Ernst, Thomas, Branford, Susan, Cayuela, Jean-Michel, Deininger, Michael, Fabarius, Alice, Kim, Dennis Dong Hwan, Machova Polakova, Katerina, Radich, Jerald P., Hehlmann, Rüdiger, Hochhaus, Andreas, Apperley, Jane F., Soverini, Simona
Publicado 2023

Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors

por Nteliopoulos, Georgios, Bazeos, Alexandra, Claudiani, Simone, Gerrard, Gareth, Curry, Edward, Szydlo, Richard, Alikian, Mary, Foong, Hui En, Nikolakopoulou, Zacharoula, Loaiza, Sandra, Khorashad, Jamshid S., Milojkovic, Dragana, Perrotti, Danilo, Gale, Robert Peter, Foroni, Letizia, Apperley, Jane F.
Publicado 2019

Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease

por Khoder, Ahmad, Alsuliman, Abdullah, Basar, Rafet, Sobieski, Catherine, Kondo, Kayo, Alousi, Amin Majid, Szydlo, Richard, Muftuoglu, Muharrem, Shaim, Hila, Apperley, Jane F., Gokdemir, Elif, Cooper, Nichola, Mehta, Rohtesh S., Marin, David, Champlin, Richard, Shpall, Elizabeth, Rezvani, Katayoun
Publicado 2018

COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

por Milojkovic, Dragana, Reynolds, Catherine J., Sandoval, Diana Mūnoz, Pieper, Franziska P., Liu, Siyi, Pade, Corinna, Gibbons, Joseph M., McKnight, Áine, Loaiza, Sandra, Palanicawander, Renuka, Innes, Andrew J., Claudiani, Simone, Apperley, Jane F., Altmann, Daniel M., Boyton, Rosemary J.
Publicado 2022

Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis

por Claudiani, Simone, Mason, Clinton C., Milojkovic, Dragana, Bianchi, Andrea, Pellegrini, Cristina, Di Marco, Antinisca, Fiol, Carme R., Robinson, Mark, Ponnusamy, Kanagaraju, Mokretar, Katya, Chowdhury, Avirup, Albert, Michael, Reid, Alistair G., Deininger, Michael W., Naresh, Kikkeri, Apperley, Jane F., Khorashad, Jamshid S.
Publicado 2021

Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies

por Cook, Lucy B., O’Dell, Gillian, Vourvou, Eleni, Palanicawandar, Renuka, Marks, Sasha, Milojkovic, Dragana, Apperley, Jane F., Loaiza, Sandra, Claudiani, Simone, Bua, Marco, Hockings, Catherine, Macdonald, Donald, Chaidos, Aris, Pavlu, Jiri, Cooper, Nichola, Fidler, Sarah, Randell, Paul, Innes, Andrew J.
Publicado 2022

A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantation

por Paul, Dirk S., Jones, Allison, Sellar, Rob S., Mayor, Neema P., Feber, Andrew, Webster, Amy P., Afonso, Neuza, Sergeant, Ruhena, Szydlo, Richard M., Apperley, Jane F., Widschwendter, Martin, Mackinnon, Stephen, Marsh, Steven G. E., Madrigal, J. Alejandro, Rakyan, Vardhman K., Peggs, Karl S., Beck, Stephan
Publicado 2015